184 related articles for article (PubMed ID: 16785804)
1. F-18 FDG whole-body PET for the assessment of disease activity in patients with rheumatoid arthritis.
Goerres GW; Forster A; Uebelhart D; Seifert B; Treyer V; Michel B; von Schulthess GK; Kaim AH
Clin Nucl Med; 2006 Jul; 31(7):386-90. PubMed ID: 16785804
[TBL] [Abstract][Full Text] [Related]
2. Whole-body FDG-PET/CT on rheumatoid arthritis of large joints.
Kubota K; Ito K; Morooka M; Mitsumoto T; Kurihara K; Yamashita H; Takahashi Y; Mimori A
Ann Nucl Med; 2009 Nov; 23(9):783-91. PubMed ID: 19834653
[TBL] [Abstract][Full Text] [Related]
3. The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT.
Okamura K; Yonemoto Y; Arisaka Y; Takeuchi K; Kobayashi T; Oriuchi N; Tsushima Y; Takagishi K
Rheumatology (Oxford); 2012 Aug; 51(8):1484-91. PubMed ID: 22513145
[TBL] [Abstract][Full Text] [Related]
4. Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET.
Beckers C; Ribbens C; André B; Marcelis S; Kaye O; Mathy L; Kaiser MJ; Hustinx R; Foidart J; Malaise MG
J Nucl Med; 2004 Jun; 45(6):956-64. PubMed ID: 15181130
[TBL] [Abstract][Full Text] [Related]
5. Semi-quantitative analysis of
Ravikanth R; Singh JK
World J Nucl Med; 2020; 19(4):347-352. PubMed ID: 33623503
[No Abstract] [Full Text] [Related]
6. Demonstrating disease activity in patients with rheumatoid arthritis. Is 18F FDG PET a sensitive method?
Karapolat I; Sertpoyraz F; Oncel G; Kobak S; Yalcin M; Kumanlioglu K
Nuklearmedizin; 2013 Dec; 52(6):244-9. PubMed ID: 24081426
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET as a tool to predict the clinical outcome of infliximab treatment of rheumatoid arthritis: an explorative study.
Elzinga EH; van der Laken CJ; Comans EF; Boellaard R; Hoekstra OS; Dijkmans BA; Lammertsma AA; Voskuyl AE
J Nucl Med; 2011 Jan; 52(1):77-80. PubMed ID: 21149486
[TBL] [Abstract][Full Text] [Related]
8. FDG PET Imaging of Extremities in Rheumatoid Arthritis.
Dhawan R; Lokitz K; Lokitz S; Caldito G; Takalkar AM
J La State Med Soc; 2016; 168(5):156-161. PubMed ID: 27797345
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of an
Lee SJ; Jeong JH; Lee CH; Ahn BC; Eun JS; Kim NR; Kang JW; Nam EJ; Kang YM
Arthritis Rheumatol; 2019 Aug; 71(8):1232-1240. PubMed ID: 30771237
[TBL] [Abstract][Full Text] [Related]
10. Rheumatoid hand joint synovitis: gray-scale and power Doppler US quantifications following anti-tumor necrosis factor-alpha treatment: pilot study.
Ribbens C; André B; Marcelis S; Kaye O; Mathy L; Bonnet V; Beckers C; Malaise MG
Radiology; 2003 Nov; 229(2):562-9. PubMed ID: 12970463
[TBL] [Abstract][Full Text] [Related]
11. (18) F-FDG PET imaging of rheumatoid articular and extraarticular synovitis.
Fonseca A; Wagner J; Yamaga LI; Osawa A; da Cunha ML; Scheinberg M
J Clin Rheumatol; 2008 Oct; 14(5):307. PubMed ID: 18838912
[No Abstract] [Full Text] [Related]
12. High-resolution (18)F-FDG PET/CT for assessing disease activity in rheumatoid and psoriatic arthritis: findings of a prospective pilot study.
Chaudhari AJ; Ferrero A; Godinez F; Yang K; Shelton DK; Hunter JC; Naguwa SM; Boone JM; Raychaudhuri SP; Badawi RD
Br J Radiol; 2016 Jul; 89(1063):20160138. PubMed ID: 27109738
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Large Joint Destruction in Patients With Rheumatoid Arthritis Using 18F-FDG PET/CT and Disease Activity Score.
Suto T; Okamura K; Yonemoto Y; Okura C; Tsushima Y; Takagishi K
Medicine (Baltimore); 2016 Feb; 95(7):e2841. PubMed ID: 26886646
[TBL] [Abstract][Full Text] [Related]
14. [Positron emission tomography with (18)F-FDG in the evaluation of patients with rheumatoid arthritis--a systematic review].
dos Anjos DA; da Mota LM
Rev Bras Reumatol; 2014; 54(6):474-82. PubMed ID: 25458029
[TBL] [Abstract][Full Text] [Related]
15. 2-Deoxy-2-[F-18]fluoro-D-glucose joint uptake on positron emission tomography images: rheumatoid arthritis versus osteoarthritis.
Elzinga EH; van der Laken CJ; Comans EF; Lammertsma AA; Dijkmans BA; Voskuyl AE
Mol Imaging Biol; 2007; 9(6):357-60. PubMed ID: 17902022
[TBL] [Abstract][Full Text] [Related]
16. (18)F-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3.
Beckers C; Jeukens X; Ribbens C; André B; Marcelis S; Leclercq P; Kaiser MJ; Foidart J; Hustinx R; Malaise MG
Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):275-80. PubMed ID: 16247604
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography/computed tomography imaging and rheumatoid arthritis.
Wang SC; Xie Q; Lv WF
Int J Rheum Dis; 2014 Mar; 17(3):248-55. PubMed ID: 24606324
[TBL] [Abstract][Full Text] [Related]
18. [(18)]F FDG PET/CT imaging to monitor the therapeutic effect of liposome-encapsulated prednisolone in experimental rheumatoid arthritis.
van der Geest T; Metselaar JM; Gerrits D; van Lent PL; Storm G; Laverman P; Boerman OC
J Control Release; 2015 Jul; 209():20-6. PubMed ID: 25902038
[TBL] [Abstract][Full Text] [Related]
19. Comparison of methods of quantifying global synovial metabolic activity with FDG-PET/CT in rheumatoid arthritis.
Raynor WY; Jonnakuti VS; Zirakchian Zadeh M; Werner TJ; Cheng G; Zhuang H; Høilund-Carlsen PF; Alavi A; Baker JF
Int J Rheum Dis; 2019 Dec; 22(12):2191-2198. PubMed ID: 31721461
[TBL] [Abstract][Full Text] [Related]
20. [18F]fluorodeoxyglucose uptake as a predictor of large joint destruction in patients with rheumatoid arthritis.
Yonemoto Y; Okamura K; Takeuchi K; Kaneko T; Kobayashi T; Okura C; Tsushima Y; Takagishi K
Rheumatol Int; 2016 Jan; 36(1):109-15. PubMed ID: 26232929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
